Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma

Technology appraisal guidance
Reference number: TA169
Published: 25 March 2009

Appendix B: proposal paper presented to the institute's guidance executive

Appendix B: proposal paper presented to the institute's guidance executive

Appendix B: proposal paper presented to the institute's guidance executive
09 March 2012
(178.71 Kb 52 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 09 March 2012